Pharmather (CSE: PHRM) is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.  Pharmather was founded with a particular focus on repurposing psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system.  

Their team includes world-class strategic partners, advisors and a strong leadership team with a proven track record of success in drug development, business development and capital markets.  

Pharmather’s goal is to advance the development of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.  For more information, visit

Recent News

Get the Pharmather
Investor’s Kit now.


Market Cap